Trials / Completed
CompletedNCT07353320
Probiotics Regulate Intestinal Health and Alleviate Anxiety
Effects of Probiotics on Alleviating Anxiety and Depression and Gut Microbiota
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Wecare Probiotics Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study is a randomized, double-blind, placebo-controlled trial aimed primarily at investigating the effects of Weizmannia coagulans BC99 on alleviating anxiety and depression and the gut microbiota.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | probiotics group | The intervention lasted 8 weeks, with follow-ups at weeks 0 and 12. |
| DIETARY_SUPPLEMENT | Placebo Group | The intervention lasted 8 weeks, with follow-ups at weeks 0 and 12. |
Timeline
- Start date
- 2024-04-10
- Primary completion
- 2024-06-05
- Completion
- 2025-04-01
- First posted
- 2026-01-20
- Last updated
- 2026-01-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07353320. Inclusion in this directory is not an endorsement.